J&J gives notice to terminate Emergent manufacturing deal for COVID vaccine

Published by

(Reuters) – Johnson & Johnson said on Monday it had formally informed Emergent BioSolutions Inc of its decision to terminate agreement with the contract manufacturer to make COVID-19 vaccine for the drugmaker. The termination notice comes about a week after J&J had initially informed Emergent of its intent to end the pact based on the contract manufacturer’s breaches, including failure to supply COVID-19 vaccine drug substance, J&J said. Emergent said earlier on Monday that J&J breached an agreement by failing to buy the minimum quantity of COVID-19 vaccines made by the company. The contract m…

Read More

Leave a Reply